Life Science Virtual Investor Forum Agenda Announced for September 18th

Life Science Virtual Investor Forum Agenda Announced for September 18th

Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Science Virtual Investor Forum to be held September 18th. This event is co-hosted by Zacks SCR.

Individual investors, institutional investors, advisors, and analysts are invited to attend.

REGISTER HERE

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.

Please schedule 1x1 meetings here

"We are excited to highlight today's innovators from the life science sector ," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Our Virtual Investor Conferences empower investors to connect and understand the vision driving these companies firsthand."

September 18 th

Eastern
Time (ET)
Presentation Ticker(s)
9:30 AM ET Amplia Therapeutics Limited (Pink: INNMF | ASX: ATX)
10:00 AM ET Kelyniam Global, Inc. (OTCID: KLYG)
10:30 AM ET United Health Products, Inc. (OTCQB: UEEC)
11:00 AM ET PetVivo Holdings, Inc. (OTCQX: PETV)
11:30 AM ET Dermata Therapeutics, Inc. (NASDAQ: DRMA)
12:00 PM ET Hemostemix Inc. (OTCQB: HMTXF | TSXV: HEM)
12:30 PM ET Lipella Pharmaceuticals Inc. (OTCID: LIPO)
2:00 PM ET InMed Pharmaceuticals Inc. (NASDAQ: INM)
2:30 PM ET Accustem Sciences Inc. (OTCQB: ACUT)
3:00 PM ET Sigyn Therapeutics Inc. (OTCQB: SIGY)
4:00 PM ET Percheron Therapeutics Ltd. (OTCID: PERCF | ASX: PER)


To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com .

About Virtual Investor Conferences ®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

INM
InMed Pharmaceuticals

InMed Pharmaceuticals Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
InMed Pharmaceuticals (NASDAQ:INM)

InMed Pharmaceuticals

Innovating cannabinoid-inspired medicines, backed by real revenue and a clear path to value

Innovating cannabinoid-inspired medicines, backed by real revenue and a clear path to value Keep Reading...
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company... Keep Reading...
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today reports financial results for its first quarter of... Keep Reading...
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. John Bathery to its Board of Directors,... Keep Reading...
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the appointment of Mr. Neil Klompas, CPA, CA to its Board of... Keep Reading...
InMed Pharmaceuticals

InMed Pharmaceuticals Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News